Genmab A/S
GMAB
$20.25
$0.050.25%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 12.76% | 4.73% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 12.76% | 4.73% | |||
| Cost of Revenue | 19.72% | 46.74% | |||
| Gross Profit | 12.40% | 3.20% | |||
| SG&A Expenses | 40.04% | -1.19% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 18.33% | -2.57% | |||
| Operating Income | 3.76% | 19.17% | |||
| Income Before Tax | 103.22% | -17.46% | |||
| Income Tax Expenses | -152.02% | -35.66% | |||
| Earnings from Continuing Operations | 194.55% | -8.17% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 194.55% | -8.17% | |||
| EBIT | 3.76% | 19.17% | |||
| EBITDA | 3.63% | 19.41% | |||
| EPS Basic | 194.38% | -6.80% | |||
| Normalized Basic EPS | 126.16% | -25.89% | |||
| EPS Diluted | 193.41% | -6.77% | |||
| Normalized Diluted EPS | 125.43% | -25.86% | |||
| Average Basic Shares Outstanding | 0.06% | -1.47% | |||
| Average Diluted Shares Outstanding | 0.39% | -1.51% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
